Alternative therapeutic options in patients with advanced gastrointestinal cancer.

por Wishart, G. C., Cooke, T. G.
Publicado 1995

Tamoxifen: the drug that came in from the cold

por Hughes-Davies, L, Caldas, C, Wishart, G C
Publicado 2009

Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England

por Ali, A M G, Greenberg, D, Wishart, G C, Pharoah, P
Publicado 2011

Radiological staging in breast cancer: which asymptomatic patients to image and how

por Barrett, T, Bowden, D J, Greenberg, D C, Brown, C H, Wishart, G C, Britton, P D
Publicado 2009

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

por Maishman, T, Copson, E, Stanton, L, Gerty, S, Dicks, E, Durcan, L, Wishart, G C, Pharoah, P, Eccles, D
Publicado 2015

P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies.

por Wishart, G. C., Plumb, J. A., Going, J. J., McNicol, A. M., McArdle, C. S., Tsuruo, T., Kaye, S. B.
Publicado 1990

Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?

por Wishart, G C, Greenberg, D C, Britton, P D, Chou, P, Brown, C H, Purushotham, A D, Duffy, S W
Publicado 2008

One-stop diagnostic breast clinics: how often are breast cancers missed?

por Britton, P, Duffy, S W, Sinnatamby, R, Wallis, M G, Barter, S, Gaskarth, M, O'Neill, A, Caldas, C, Brenton, J D, Forouhi, P, Wishart, G C
Publicado 2009

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival

por Dawson, S J, Duffy, S W, Blows, F M, Driver, K E, Provenzano, E, LeQuesne, J, Greenberg, D C, Pharoah, P, Caldas, C, Wishart, G C
Publicado 2009

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

por Warren, R M L, Bobrow, L G, Earl, H M, Britton, P D, Gopalan, D, Purushotham, A D, Wishart, G C, Benson, J R, Hollingworth, W
Publicado 2004

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

por Wishart, G C, Bajdik, C D, Dicks, E, Provenzano, E, Schmidt, M K, Sherman, M, Greenberg, D C, Green, A R, Gelmon, K A, Kosma, V-M, Olson, J E, Beckmann, M W, Winqvist, R, Cross, S S, Severi, G, Huntsman, D, Pylkäs, K, Ellis, I, Nielsen, T O, Giles, G, Blomqvist, C, Fasching, P A, Couch, F J, Rakha, E, Foulkes, W D, Blows, F M, Bégin, L R, van't Veer, L J, Southey, M, Nevanlinna, H, Mannermaa, A, Cox, A, Cheang, M, Baglietto, L, Caldas, C, Garcia-Closas, M, Pharoah, P D P
Publicado 2012